Who
Indranil Dey
President and CEO
Company insider
Files Form 4 as: President and CEO, Bluejay Diagnostics.
In numbers
- Trades disclosed
- 12
- Buys
- 4
- Sells
- 0
- Bought
- $56K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 25 Feb 2022
- Last trade
- 17 Aug 2026
- Last filed
- 18 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 17 Aug 2026filed 18 Aug 2026 | BJDX Bluejay DiagnosticsMedical Devices | SEC FORM 4 Code A | —28,000 at $0.00 | filing |
| 17 Aug 2026filed 18 Aug 2026 | BJDX Bluejay DiagnosticsMedical Devices | SEC FORM 4 Code A | —28,000 at $0.00 | filing |
| 14 Mar 2026filed 18 May 2026 | BJDX Bluejay DiagnosticsMedical Devices | SEC FORM 4 Bought | $25K12,500 at $2.00 | filing |
| 14 Mar 2026filed 18 May 2026 | BJDX Bluejay DiagnosticsMedical Devices | SEC FORM 4 Bought | $25K12,500 at $2.00 | filing |
| 13 Dec 2023filed 14 Dec 2023 | BJDX Bluejay DiagnosticsMedical Devices | SEC FORM 4 Bought | $1,635500 at $3.27 | filing |
| 28 Mar 2023filed 31 Mar 2023 | BJDX Bluejay DiagnosticsMedical Devices | SEC FORM 4 Bought | $8802,000 at $0.44 | filing |
| 28 Mar 2023filed 28 Mar 2023 | BJDX Bluejay DiagnosticsMedical Devices | SEC FORM 4 Code A | $8802,000 at $0.44 | filing |
| 27 Mar 2023filed 31 Mar 2023 | BJDX Bluejay DiagnosticsMedical Devices | SEC FORM 4 Bought | $3,5208,000 at $0.44 | filing |
| 27 Mar 2023filed 28 Mar 2023 | BJDX Bluejay DiagnosticsMedical Devices | SEC FORM 4 Code A | $3,5208,000 at $0.44 | filing |
| 1 Feb 2023filed 13 Feb 2023 | BJDX Bluejay DiagnosticsMedical Devices | SEC FORM 4 Code A | $70K159,090 at $0.44 | filing |
| 1 Feb 2023filed 13 Feb 2023 | BJDX Bluejay DiagnosticsMedical Devices | SEC FORM 4 Code F | $24K55,612 at $0.44 | filing |
| 25 Feb 2022filed 28 Feb 2022 | BJDX Bluejay Diagnosticsoption or derivative · Medical Devices | SEC FORM 4 Code A | —14,116 | filing |
News
No headline names them, or the companies they trade most, lately.